Botanical species · safety record

Impatiens noli-tangere

The EFSA Compendium of Botanicals holds 3 constituent measurements for Impatiens noli-tangere. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Impatiens noli-tangere L.

3Constituent measurements

0Safety records

2Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Lawsone	Aerial part of plants	Powder	0.185 Percent	HPLC with standard detection methods	No resolvable identifier
Naphthoquinones	Aerial part of plants	Powder	0.03 Percent	HPLC with standard detection methods	No resolvable identifier
Scopoletin	Aerial part of plants	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

coebogja., gimjongweon. Studies on the Constituents of Impatiens noli-tangere L.. Korean journal of pharmacognosy, 2002, vol. 33, no. 4, p. 263-266.
Lobstein, A., Brenne, X., Feist, E., Metz, N., Weniger, B., Anton, R. Quantitative determination of naphthoquinones of Impatiens species. Phytochemical Analysis, 2001, p. 202-205.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature